South Asian Journal of Cancer

LinksSchließen

Referenz

Ferrero JM, Hardy-Bessard AC, Capitain O. et al.
Weekly paclitaxel, capecitabine, and bevacizumab with maintenance capecitabine and bevacizumab as first-line therapy for triple-negative, metastatic, or locally advanced breast cancer: Results from the GINECO A-TaXel phase 2 study.

Cancer 2016;
122 (20) 3119-3126

Bibliographische Angaben herunterladen

Aufrufen in: